BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 27471274)

  • 1. Lymphocytic oesophagitis, eosinophilic oesophagitis and compound lymphocytic-eosinophilic oesophagitis I: histological and immunohistochemical findings.
    Rubio CA; Ichiya T; Schmidt PT
    J Clin Pathol; 2017 Mar; 70(3):208-216. PubMed ID: 27471274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphocytic oesophagitis: clinicopathological aspects of an emerging condition.
    Haque S; Genta RM
    Gut; 2012 Aug; 61(8):1108-14. PubMed ID: 22157333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of narrow-band imaging signs in eosinophilic and lymphocytic esophagitis.
    Ichiya T; Tanaka K; Rubio CA; Hammar U; Schmidt PT
    Endoscopy; 2017 May; 49(5):429-437. PubMed ID: 28201841
    [No Abstract]   [Full Text] [Related]  

  • 4. Atopic and non-atopic eosinophilic oesophagitis are distinguished by immunoglobulin E-bearing intraepithelial mast cells.
    Mulder DJ; Mak N; Hurlbut DJ; Justinich CJ
    Histopathology; 2012 Nov; 61(5):810-22. PubMed ID: 22978418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Automated image analysis in the study of lymphocyte subpopulation in eosinophilic oesophagitis.
    García-Rojo M; Sánchez J; de la Santa E; Durán E; Ruiz JL; Silva A; Rubio FJ; Rodríguez AM; Meléndez B; González L; López-Viedma B
    Diagn Pathol; 2014; 9 Suppl 1(Suppl 1):S7. PubMed ID: 25565117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphocytic Oesophagitis Preliminary Ultrastructural Observations.
    Rubio CA; Villnow E; Schmidt PT
    Anticancer Res; 2016 May; 36(5):2315-22. PubMed ID: 27127138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Markers of antigen presentation and activation on eosinophils and T cells in the esophageal tissue of patients with eosinophilic esophagitis.
    Le-Carlson M; Seki S; Abarbanel D; Quiros A; Cox K; Nadeau KC
    J Pediatr Gastroenterol Nutr; 2013 Mar; 56(3):257-62. PubMed ID: 23059644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Redefining the role of lymphocytes in gastroesophageal reflux disease and eosinophilic esophagitis.
    Basseri B; Levy M; Wang HL; Shaye OA; Pimentel M; Soffer EE; Conklin JL
    Dis Esophagus; 2010 Jul; 23(5):368-76. PubMed ID: 20353445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dietary treatment modulates mast cell phenotype, density, and activity in adult eosinophilic oesophagitis.
    Arias Á; Lucendo AJ; Martínez-Fernández P; González-Castro AM; Fortea M; González-Cervera J; Yagüe-Compadre JL; Mota-Huertas T; Vicario M
    Clin Exp Allergy; 2016 Jan; 46(1):78-91. PubMed ID: 25640519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pattern of esophageal eosinophilic infiltration in patients with achalasia and response to Heller myotomy and Dor fundoplication.
    Cools-Lartigue J; Chang SY; Mckendy K; Mayrand S; Marcus V; Fried GM; Ferri LE
    Dis Esophagus; 2013; 26(8):766-75. PubMed ID: 22891632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The rising incidence of eosinophilic oesophagitis is associated with increasing biopsy rates: a population-based study.
    Syed AA; Andrews CN; Shaffer E; Urbanski SJ; Beck P; Storr M
    Aliment Pharmacol Ther; 2012 Nov; 36(10):950-8. PubMed ID: 22994460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oesophageal intrasquamous IgG4 deposits: an adjunctive marker to distinguish eosinophilic oesophagitis from reflux oesophagitis.
    Zukerberg L; Mahadevan K; Selig M; Deshpande V
    Histopathology; 2016 Jun; 68(7):968-76. PubMed ID: 26466342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphocytic Esophagitis Is Not Similar to Eosinophilic Esophagitis Except for Seasonal Variation.
    Avila M; Ambelil M; Tong Y; Khurana S; Abraham F; Ertan A; Thosani NC; DuPont AW; Cash BD; Younes M
    Ann Clin Lab Sci; 2021 May; 51(3):347-351. PubMed ID: 34162564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endoscopic appearance and location dictate diagnostic yield of biopsies in eosinophilic oesophagitis.
    Salek J; Clayton F; Vinson L; Saffari H; Pease LF; Boynton K; Fang J; Cox K; Peterson KA
    Aliment Pharmacol Ther; 2015 Jun; 41(12):1288-95. PubMed ID: 25898774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphocytic Esophagitis: An Emerging Clinicopathologic Disease Associated with Dysphagia.
    Pasricha S; Gupta A; Reed CC; Speck O; Woosley JT; Dellon ES
    Dig Dis Sci; 2016 Oct; 61(10):2935-2941. PubMed ID: 27343035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The optimal number of biopsy fragments to establish a morphologic diagnosis of eosinophilic esophagitis.
    Nielsen JA; Lager DJ; Lewin M; Rendon G; Roberts CA
    Am J Gastroenterol; 2014 Apr; 109(4):515-20. PubMed ID: 24445569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of CD25, mast cell markers and T-cell markers in eosinophilic esophagitis.
    Htoo A; Qualia CM; George R; Arker SH; Subasi NB; Lee H; Chung L; Chen A
    Ann Diagn Pathol; 2024 Jun; 70():152287. PubMed ID: 38479198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Esophageal eosinophilic infiltration responds to proton pump inhibition in most adults.
    Molina-Infante J; Ferrando-Lamana L; Ripoll C; Hernandez-Alonso M; Mateos JM; Fernandez-Bermejo M; Dueñas C; Fernandez-Gonzalez N; Quintana EM; Gonzalez-Nuñez MA
    Clin Gastroenterol Hepatol; 2011 Feb; 9(2):110-7. PubMed ID: 20920599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eosinophilic oesophagitis: relevance of mast cell infiltration.
    Strasser DS; Seger S; Bussmann C; Pierlot GM; Groenen PMA; Stalder AK; Straumann A
    Histopathology; 2018 Sep; 73(3):454-463. PubMed ID: 29772120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pathomorphological criteria and features of immune response in eosinophilic esophagitis and reflux esophagitis].
    Maslenkina KS; Motylev EN; Guschin MY; Vandysheva RA; Mikhaleva LM
    Arkh Patol; 2024; 86(1):5-12. PubMed ID: 38319266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.